InvestorsHub Logo
Followers 0
Posts 121
Boards Moderated 0
Alias Born 03/10/2014

Re: DaubersUP post# 192269

Wednesday, 08/02/2017 7:18:47 AM

Wednesday, August 02, 2017 7:18:47 AM

Post# of 403033
I'm hoping we partner up with K and start some combo trials next year. Imagine we have similar/better results to what they blogged about:

http://www.ipharminc.com/new-blog/2017/5/25/p53-gene-therapy-shows-added-efficacy-when-used-in-combination

"Laboratory studies conducted by Innovation and at leading institutions on the effects of Kevetrin in combination with approved cancer drugs, including studies against renal cancer, pancreatic cancer, ovarian cancer, glioblastoma and acute myeloid leukemia, have delivered promising data supporting the ability of Kevetrin to enhance chemosensitivity."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News